ZOOMMED INC. | Sales 2022 | 11.15K 8.18K | Sales 2023 | 13.01K 9.54K | Capitalization | 2.03M 1.49M |
|---|---|---|---|---|---|
| Net income 2022 | -1M -733K | Net income 2023 | - 0 | EV / Sales 2022 | 168 x |
| Net cash position 2022 | 161K 118K | Net Debt 2023 | 393K 288K | EV / Sales 2023 | 186 x |
| P/E ratio 2022 |
-1.66
x | P/E ratio 2023 |
11.6
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.02% |
More Fundamentals
* Assessed data
More news
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Yves Marmet
CEO | Chief Executive Officer | - | 05-09-30 |
| Director of Finance/CFO | - | 05-09-30 | |
Sébastie Ouellet
CTO | Chief Tech/Sci/R&D Officer | - | 04-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Robert Powell
BRD | Director/Board Member | - | 05-01-31 |
André Marmet
PRN | Corporate Officer/Principal | - | 05-09-30 |
| Director of Finance/CFO | - | 05-09-30 |
ZoomMed Inc. is a Canada-based company, which builds and operates ZoomMedâs Communication Network, a clinical interoperable information exchange network between physicians and the various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical corporations and private insurers.
Calendar
2024-09-26
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -9.49% | 28.16B | |
| +25.35% | 8.33B | |
| +33.25% | 4.39B | |
| -35.85% | 2.43B | |
| -9.44% | 1.6B | |
| -13.39% | 1.5B | |
| -32.84% | 1.15B | |
| +7.80% | 964M | |
| -37.56% | 872M |
